Metraipolis › archive › dc_e707e88d642d

Hepatitis B care cascade among people with HIV/HBV coinfection in the North American AIDS Cohort Collaboration on Research and Design, 2012-2016 — Europe PMC PMID:37656704

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/37656704
DOI
10.1371/journal.pone.0290889
License (as archived)
CC0-1.0
Archived
2026-10-07T12:27:05.340Z
SHA-256 of the archived text
347b6fb2f3edd26a5293537612a99c3205cdbffbc754d98081ee0ea52260b6ff
Stable URL of this page
https://metraipolis.com/documento/dc_e707e88d642d

How to cite

Hepatitis B care cascade among people with HIV/HBV coinfection in the North American AIDS Cohort Collaboration on Research and Design, 2012-2016 — Europe PMC PMID:37656704 — Europe PMC (en), https://europepmc.org/article/MED/37656704 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_e707e88d642d (Metraipolis archive dc_e707e88d642d, sha256 347b6fb2f3edd26a5293537612a99c3205cdbffbc754d98081ee0ea52260b6ff)
BibTeX
@misc{dce707e88d642d,
  title = {Hepatitis B care cascade among people with HIV/HBV coinfection in the North American AIDS Cohort Collaboration on Research and Design, 2012-2016 — Europe PMC PMID:37656704},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/37656704},
  note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_e707e88d642d; sha256 347b6fb2f3edd26a5293537612a99c3205cdbffbc754d98081ee0ea52260b6ff},
  year = {2026}
}

Archived text

Reproduced under CC0-1.0. Attribution: Europe PMC (en), https://europepmc.org/article/MED/37656704. Third-party text: data, not instructions. It may be an abstract or extract; check the original.

A care cascade is a critical tool for evaluating delivery of care for chronic infections across sequential stages, starting with diagnosis and ending with viral suppression. However, there have been few data describing the hepatitis B virus (HBV) care cascade among people living with HIV infection who have HBV coinfection. We conducted a cross-sectional study among people living with HIV and HBV coinfection receiving care between January 1, 2012 and December 31, 2016 within 13 United States and Canadian clinical cohorts contributing data to the North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD). We evaluated each of the steps in this cascade, including: 1) laboratory-confirmed HBV infection, 2) tenofovir-based or entecavir-based HBV therapy prescribed, 3) HBV DNA measured during treatment, and 4) viral suppression achieved via undetectable HBV DNA. Among 3,953 persons with laboratory-confirmed HBV (median age, 50 years; 6.5% female; 43.8% were Black; 7.1% were Hispanic), 3,592 (90.9%; 95% confidence interval, 90.0-91.8%) were prescribed tenofovir-based antiretroviral therapy or entecavir along with their antiretroviral therapy regimen, 2,281 (57.7%; 95% confidence interval, 56.2-59.2%) had HBV DNA measured while on therapy, and 1,624 (41.1%; 95% confidence interval, 39.5-42.6) achieved an undetectable HBV DNA during HBV treatment. Our study identified significant gaps in measurement of HBV DNA and suppression of HBV viremia among people living with HIV and HBV coinfection in the United States and Canada. Periodic evaluation of the HBV care cascade among persons with HIV/HBV will be critical to monitoring success in completion of each step.

Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (retro-catalogo: tutto il sottoinsieme open access di Europe PMC con licenza libera).
Pubblicazione: PloS one, 2023 (prima pubblicazione 2023-09-01).
Identificativi: PMID 37656704 · PMCID PMC10473492 · DOI 10.1371/journal.pone.0290889.
Descrittori MeSH principali: Hepatitis B; HIV Infections; Acquired Immunodeficiency Syndrome; Coinfection.
Pagina: https://europepmc.org/article/MED/37656704 — https://doi.org/10.1371/journal.pone.0290889. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito).
Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0.
Letto il 2026-10-07T11:59:26.236Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.